Abstract introduction Chronic lymphocytic leukemia (CLL) is a disorder of mature but
dysfunctional monoclonal B cells. Microenvironment, antigenic stimulation and genetical …

Heterogeneity of CD 20 expression exists in chronic lymphocytic leukemia (CLL), therefore,
we explored the prognostic significance of CD 20 expression in Chinese patients with CLL …

Background: Identification of factors affecting prognosis in chronic lymphocytic leukemia
(CLL) is important for risk stratification of patients. Methods: In the present study, CD49d …

Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of monoclonal B
cells expressing CD19, CD5 and CD23 together with low surface expression of B-cell …

Background: In patients with chronic lymphocytic leukemia (CLL), aberrant expression of the
T‐lineage antigen CD8 was reported in low frequencies. The clinical impact of this …

Background. Chronic lymphocytic leukemia (CLL) is a condition characterized by the
accumulation of morphologically mature monoclonal lymphocytes B with the …

Clinical and Laboratory Features of CD5-Negative Chronic Lymphocytic Leukemia - PMC Back
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

Chronic lymphocytic leukaemia (CLL) is characterized by expression of CD5 on clonal B
cells, and is partly driven by activated B‐cell receptor (BCR) signalling. While CD5 is known …

Background Chronic lymphocytic leukemia is a heterogeneous disease characterized by a
highly variable clinical course. The majority of cases do not require therapy and show …

CD49d plays a critical role in leucocyte trafficking, activation and survival, and facilitates
interactions between leucocytes and stromal cells. Recent data give evidence for the …